Can We use delayed consolidation in chronic lymphocytic leukemia?

The most recently developed initial treatment regimens for chronic lymphocytic leukemia (CLL) are fixed-duration combinations of an inhibitor of Bruton tyrosine kinase (BTKi) and a B-cell lymphoma ...

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-11-14
DOI
https://doi.org/10.1080/10428194.2026.2759560
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Can We use delayed consolidation in chronic lymphocytic leukemia?

Kerry Anne Rogers, Philip A. Thompson
Leukemia & lymphoma/Leukemia and lymphoma
Chronic Lymphocytic Leukemia Research
article

Can We use delayed consolidation in chronic lymphocytic leukemia?

Kerry Anne Rogers, Philip A. Thompson
article en

Abstract

The most recently developed initial treatment regimens for chronic lymphocytic leukemia (CLL) are fixed-duration combinations of an inhibitor of Bruton tyrosine kinase (BTKi) and a B-cell lymphoma ...

Leukemia & lymphoma/Leukemia and lymphoma
Peter MacCallum Cancer Centre (AU), The Ohio State University (US)
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon